Lawrence Steinman, Director at BioAtla, Inc. (BCAB), sold 450 shares at $30.00 ($14K) on 2021-11-02, disclosed to the SEC on 2021-11-03.
Scheduled sale ($14k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KTTA | BUY | 2023-06-06 | $13K | — | Filing → |
| ATNF | BUY | 2023-06-02 | $22K | — | Filing → |
| ATNF | BUY | 2021-12-10 | $21K | — | Filing → |